Works matching IS 14783223 AND DT 2023 AND VI 43 AND IP 1


Results: 43
    1
    2

    Issue Information.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. i, doi. 10.1111/liv.15713
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Treatment of hepatitis delta and HIV infection.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. 108, doi. 10.1111/liv.15345
    By:
    • Soriano, Vicente;
    • de Mendoza, Carmen;
    • Treviño, Ana;
    • Ramos‐Rincón, José Manuel;
    • Moreno‐Torres, Víctor;
    • Corral, Octavio;
    • Barreiro, Pablo
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. 77, doi. 10.1111/liv.15465
    By:
    • Yuen, Man‐Fung;
    • Chen, Chi‐Yi;
    • Liu, Chun‐Jen;
    • Jeng, Wen‐Juei;
    • Elkhashab, Magdy;
    • Coffin, Carla S.;
    • Kim, Won;
    • Greenbloom, Susan;
    • Ramji, Alnoor;
    • Lim, Young S.;
    • Kim, Yoon J.;
    • Fung, Scott K.;
    • Kim, Dong J.;
    • Jang, Jeong‐Won;
    • Lee, Kwan Sik;
    • Iyer, Radhakrishnan P.;
    • Macfarlane, Chelsea;
    • Jackson, Kathy;
    • Locarnini, Stephen A.;
    • Chan, Henry L. Y.
    Publication type:
    Article
    20

    Hepatic Leukaemia.

    Published in:
    2023
    By:
    • Prasoppokakorn, Thaninee;
    • Sanpavat, Anapat
    Publication type:
    Case Study
    21
    22
    23
    24
    25
    26
    27
    28
    29

    DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. 208, doi. 10.1111/liv.15383
    By:
    • Jarman, Edward J.;
    • Horcas‐Lopez, Marta;
    • Waddell, Scott H.;
    • MacMaster, Stephanie;
    • Gournopanos, Konstantinos;
    • Soong, Daniel Y. H.;
    • Musialik, Kamila I.;
    • Tsokkou, Panagiota;
    • Ng, Minn‐E;
    • Cambridge, William A.;
    • Wilson, David H.;
    • Kagey, Michael H.;
    • Newman, Walter;
    • Pollard, Jeffrey W.;
    • Boulter, Luke
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Pulmonary impairment independently determines mortality in critically ill patients with acute‐on‐chronic liver failure.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. 180, doi. 10.1111/liv.15343
    By:
    • Schulz, Martin S.;
    • Mengers, Jan;
    • Gu, Wenyi;
    • Drolz, Andreas;
    • Ferstl, Philip G.;
    • Amoros, Alex;
    • Uschner, Frank E.;
    • Ackermann, Nora;
    • Guttenberg, Georg;
    • Queck, Alexander;
    • Brol, Maximilian J.;
    • Graf, Christiana;
    • Stoffers, Philipp;
    • de la Vera, Anna‐Lena Laguna;
    • Cremonese, Carla;
    • Erasmus, Hans‐Peter;
    • Welker, Martin W.;
    • Grünewaldt, Achim;
    • Arroyo, Vincente;
    • Bojunga, Jörg
    Publication type:
    Article
    36
    37
    38

    Issue Information.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. 1, doi. 10.1111/liv.15298
    Publication type:
    Article
    39
    40
    41
    42

    Impact on follow‐up strategies in patients with primary sclerosing cholangitis.

    Published in:
    Liver International, 2023, v. 43, n. 1, p. 127, doi. 10.1111/liv.15286
    By:
    • Bergquist, Annika;
    • Weismüller, Tobias J.;
    • Levy, Cynthia;
    • Rupp, Christian;
    • Joshi, Deepak;
    • Nayagam, Jeremy Shanika;
    • Montano‐Loza, Aldo J.;
    • Lytvyak, Ellina;
    • Wunsch, Ewa;
    • Milkiewicz, Piotr;
    • Zenouzi, Roman;
    • Schramm, Christoph;
    • Cazzagon, Nora;
    • Floreani, Annarosa;
    • Liby, Ingalill Friis;
    • Wiestler, Miriam;
    • Wedemeyer, Heiner;
    • Zhou, Taotao;
    • Strassburg, Christian P.;
    • Rigopoulou, Eirini
    Publication type:
    Article
    43